Meyka AI API is live for developers.Start building.
Advertisement
Personalis, Inc.

Personalis, Inc. (PSNL) Stock Overview

Explore Personalis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PSNLNASDAQ
HealthcareMedical - Diagnostics & Research
$10.75
$1.35(11.16%)
U.S. Market opens in 51h 58m
Advertisement

Personalis, Inc. (PSNL)

Meyka AI Score

Z

Key Financials

Market Cap954.6M
P/E Ratio-11.38
EPS (TTM)$-1.02
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$8.42
3 Months$8.85
1 Year Target$11.47

PSNL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Personalis, Inc. (PSNL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.47.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.38 and a market capitalization of 954.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-11.16%
5-Day Change
-0.56%
1-Month Change
93.35%
3-Month Change
25.58%
6-Month Change
12.45%
Year-to-Date (YTD) Change
35.05%
1-Year Change
112.45%
3-Year Change
344.21%
5-Year Change
-52.97%
All-Time (Max) Change
-62.27%

Contact Information

650 752 1300
1330 O’Brien Drive, Fremont, CA, 94025

Company Facts

228 Employees
IPO DateJun 20, 2019
CountryUS
Actively Trading

Frequently Asked Questions